Search results for "DYAX"

REFINE RESULTS

SEARCH RESULTS

About 3 results. Sort By: Date | Relevance
Shire, Baxalta combine into rare diseases leader

Shire clinched its six-month pursuit of Baxalta by agreeing to a $32 billion cash and stock offer.
Source: Reuters
UPDATE 4-Drugmaker Shire to buy Baxalta for $32 bln after 6-month pursuit

*Deal offers $18 and 0.1482 Shire ADS per Baxalta share. LONDON, Jan 11- Drugmaker Shire Plc clinched its six-month pursuit of Baxalta International Inc on Monday with an agreed $32 billion cash and stock offer, catapulting it to a leading position in treating rare diseases. Shareholders will receive $18 in cash and 0.1482 Shire American depositary share per...
Source: Reuters | By: Ben Hirschler and Paul Sandle
UPDATE 3-Drugmaker Shire buys Baxalta for $32 bln after 6-month pursuit

*Deal offers $18 and 0.1482 Shire ADS per Baxalta share. LONDON, Jan 11- Drugmaker Shire Plc clinched its six-month pursuit of Baxalta International Inc on Monday with an agreed $32 billion cash and stock offer, catapulting it to a leading position in treating rare diseases. Shareholders will receive $18 in cash and 0.1482 Shire American depositary share per...
Source: Reuters | By: Ben Hirschler and Paul Sandle